Benzinga
-
Biotricity Invites Physicians to Join Shared Revenue Opportunity, Provides Clinics with Remote Devices for Improved Monitoring and Diagnosis
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Ranked as one of the fastest-growing companies in the healthcare sector, Biotricity Inc. (NASDAQ: BTCY) sets out to leave an imprint on all 50 states with its connected, real-time monitoring medtech device. For the last 19 months, Dr. Waqaas Al-Siddiq, CEO, chairman and founder of Biotricity, has led his company to list on a major exchange and expand into 23 different states across the U.S. The company’s flagship device — the Bioflux — is a wearable that gives doctors and cardiologists the ability to monitor and diagnose…
-
Sustainability vs. Extractive Industries – Can They Co-Exist? This Company Thinks So
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Is it possible for mining methods and environmental sustainability to co-exist on a more intimate level? A Québec, Canada, battery materials company believes that with a higher set of standards and a stronger emphasis on accountability, it’s possible. It says that it is showing the world firsthand what it takes to be environmentally responsible by touching on the social component, the financial performance, and the long-term perspective — regardless of the stigma mining has earned to the contrary. The company states that it was…
You May Also Like
NASA-Approved Technologies Essential to Creating Cooler, Lighter and Safer Batteries for EV, Aeronautics and Smart Device Technologies
Worksport Makes the Impossible Possible: Green-Energy Microgrid Systems Power EV Trucking and Off-Grid Lifestyling
This Fun Utility Vehicle (FUV) Makes You Wish You Had One or Two or a Fleet
- IoT, Benzinga, Biographies, Business, CleanTech, Finance, Industry, Smart Buildings, Smart Cities, Technology
The Internet of People — How One Man’s Passion Empowers the IotaCommUnity
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. In a play on words, Terrence DeFranco points out that “comm” represents both communications and community. DeFranco, the CEO and president of IotaComm stresses that it’s the community that makes what his company does so important and why his solutions are designed with an extreme sense of purpose. Every successful company begins with a story. And, many stories start with a founder who had a deep-rooted passion to make a difference in the world. It’s those emotions that drive people to create, take action and solve…
You May Also Like
Biotricity Reports Q1 Earnings at 290% for FY2022
Biotricity Invites Physicians to Join Shared Revenue Opportunity, Provides Clinics with Remote Devices for Improved Monitoring and Diagnosis
Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring
-
Is Generation Hemp Now A Leader in Pure-Play Hemp Operations for the Industrial Sector?
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. A leader in the “Industrial Evolution,” Generation Hemp, Inc. (OTCQB: GENH) is showing the world just what it means to be a pure-play business — especially when it comes to industrial hemp operations. Generation Hemp focuses solely on the practical and industrial use of hemp and its byproducts, ensuring no part of this “wonder plant” goes to waste. As the hemp industry continues to blossom, Generation Hemp moves ahead to serve and target within the midstream sector, vertically integrating along the supply chain through acquisitions of successful…
-
Groundbreaking Studies to Be Conducted on the Effectiveness of Short and Long-term COVID-19 Therapies Inhibiting the Progression of SARS-CoV-2
Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Statera Biopharma, Inc. (NASDAQ: STAB) recently announced that it has officially received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment in the mitigation of SARS-CoV-2 progression. STAT-205 is a breakthrough immuno-modulator designed to decrease elevated inflammatory responses that are associated with viral infections and inhibit viral replication in human lung cells. Its efficacy was successfully demonstrated during preclinical in vitro studies, where STAT-205 was able to inhibit the replication of…
